Paulina Olszewska Selected Research

Lactoferrin

9/2022	Human Lactoferrin Synergizes with Etoposide to Inhibit Lung Adenocarcinoma Cell Growth While Attenuating Etoposide-Mediated Cytotoxicity of Human Endothelial Cells.
11/2021	A Novel Human Recombinant Lactoferrin Inhibits Lung Adenocarcinoma Cell Growth and Migration with No Cytotoxic Effect on Normal Human Epithelial Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paulina Olszewska Research Topics

Disease

8	Neoplasms (Cancer) 09/2022 - 01/2013
3	Adenocarcinoma of Lung 09/2022 - 04/2014
3	Lung Neoplasms (Lung Cancer) 03/2017 - 04/2014
3	Hypoxia (Hypoxemia) 02/2014 - 05/2009
1	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2017

Drug/Important Bio-Agent (IBA)

3	Caspase 3 (Caspase-3)IBA 11/2021 - 02/2014
2	LactoferrinIBA 09/2022 - 11/2021
2	AcidsIBA 03/2017 - 04/2014
2	AcridinesIBA 03/2017 - 04/2014
2	CarbonIBA 10/2014 - 04/2014
2	azomycinIBA 02/2014 - 01/2013
2	Tirapazamine (SR 4233)IBA 02/2014 - 01/2013
2	MisonidazoleIBA 02/2014 - 01/2013
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2014 - 01/2013
1	Etoposide (VP 16)FDA LinkGeneric 09/2022
1	Histones (Histone)IBA 03/2017
1	Phosphotransferases (Kinase)IBA 03/2017
1	4-fluorobenzoic acidIBA 10/2014
1	quinolineIBA 04/2014
1	DNA (Deoxyribonucleic Acid)IBA 02/2014
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2009
1	Thrombin FDA Link 05/2009
1	Messenger RNA (mRNA)IBA 05/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2009
1	Nitric Oxide Synthase (NO Synthase)IBA 05/2009

Therapy/Procedure

3	Therapeutics 11/2021 - 03/2017